Development of a scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa.

Development of a scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa.

Item
http://www.wikidata.org/entity/Q34275205
Tryptophan-induced eosinophilia-myalgia syndrome.Epidemiology of scleroderma.Hypodense eosinophils and interleukin 5 activity in the blood of patients with the eosinophilia-myalgia syndromePathological and immunological effects of ingesting L-tryptophan and 1,1'-ethylidenebis (L-tryptophan) in Lewis rats.Dilatation of high endothelial venules in compartments of rat lymph nodes with abundant cortical mast cells.L-tryptophan implicated in human eosinophilia-myalgia syndrome causes fasciitis and perimyositis in the Lewis rat.Abnormalities of the coronary arteries, neural structures and conduction system of the heart observed postmortem in the eosinophilia-myalgia syndrome, with a discussion of comparative findings from the toxic oil syndrome.Clinical aspects of systemic sclerosis (scleroderma).Serotonin paracrine signaling in tissue fibrosisDrug-induced rheumatic syndromes. Diagnosis, clinical features and management.The eosinophilia-myalgia syndrome.Scleroderma after therapy with appetite suppressants. Report on four cases.Indoleamine 2, 3-dioxygenase (IDO) is essential for dendritic cell activation and chemotactic responsiveness to chemokines.Systemic sclerosis--a microvascular disorder?L-tryptophan Induced Eosinophilia-Myalgia Syndrome
P2860

Development of a scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa.

Item
http://www.wikidata.org/entity/Q34275205
description
1980 nî lūn-bûn
@nan
1980 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1980 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
name
Development of a scleroderma-l ...... droxytryptophan and carbidopa.
@ast
Development of a scleroderma-l ...... droxytryptophan and carbidopa.
@en
Development of a scleroderma-l ...... droxytryptophan and carbidopa.
@nl
type
label
Development of a scleroderma-l ...... droxytryptophan and carbidopa.
@ast
Development of a scleroderma-l ...... droxytryptophan and carbidopa.
@en
Development of a scleroderma-l ...... droxytryptophan and carbidopa.
@nl
prefLabel
Development of a scleroderma-l ...... droxytryptophan and carbidopa.
@ast
Development of a scleroderma-l ...... droxytryptophan and carbidopa.
@en
Development of a scleroderma-l ...... droxytryptophan and carbidopa.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Development of a scleroderma-l ...... droxytryptophan and carbidopa.
@en
P2093
P304
P31
P356
10.1056/NEJM198010023031403
P407
P433
P478
P577
P698